Soluble Nogo-Receptor-Fc decoy (AXER-204) in patients with chronic cervical spinal cord injury in the USA: a first-in-human and randomised clinical trial
George Maynard, Ramakrishnan Kannan, Jian Liu, Weiwei Wang, Tu Kiet T. Lam, Xingxing Wang, Crista Adamson, Craig Hackett, Jan M. Schwab, Charles Liu, Donald P. Leslie, David Chen, Ralph Marino, Ross Zafonte, Adam Flanders, Gilbert Block, Erika Smith, Stephen M. Strittmatter
Dive into the research topics of 'Soluble Nogo-Receptor-Fc decoy (AXER-204) in patients with chronic cervical spinal cord injury in the USA: a first-in-human and randomised clinical trial'. Together they form a unique fingerprint.
Keyphrases
Medicine and Dentistry
Pharmacology, Toxicology and Pharmaceutical Science